WO2011141822A3 - Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors - Google Patents

Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors Download PDF

Info

Publication number
WO2011141822A3
WO2011141822A3 PCT/IB2011/001447 IB2011001447W WO2011141822A3 WO 2011141822 A3 WO2011141822 A3 WO 2011141822A3 IB 2011001447 W IB2011001447 W IB 2011001447W WO 2011141822 A3 WO2011141822 A3 WO 2011141822A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
ppar
induction
modulation
treatment
Prior art date
Application number
PCT/IB2011/001447
Other languages
French (fr)
Other versions
WO2011141822A2 (en
Inventor
Wojtek Krezel
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Centre National De La Recherche Scientifique (Cnrs)
Université De Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Centre National De La Recherche Scientifique (Cnrs), Université De Strasbourg filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of WO2011141822A2 publication Critical patent/WO2011141822A2/en
Publication of WO2011141822A3 publication Critical patent/WO2011141822A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to methods for modulating or detecting changes in peroxisome proliferator activated receptors (PPARs) and retinoid X receptors (RXR) to: 1) treat certain neuropsychiatric disorders, 2) identify susceptibility to such disorders in a clinical setting, and 3) screen novel pharmacological agents, including retinoids and retinoid derivatives for adverse psychiatric side-effects, and 4) generate certain neuropsychiatric disorders in preclinical conditions.
PCT/IB2011/001447 2010-05-11 2011-05-11 Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors WO2011141822A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33372710P 2010-05-11 2010-05-11
US33372510P 2010-05-11 2010-05-11
US61/333,727 2010-05-11
US61/333,725 2010-05-11

Publications (2)

Publication Number Publication Date
WO2011141822A2 WO2011141822A2 (en) 2011-11-17
WO2011141822A3 true WO2011141822A3 (en) 2012-03-29

Family

ID=44630266

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/001447 WO2011141822A2 (en) 2010-05-11 2011-05-11 Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors

Country Status (1)

Country Link
WO (1) WO2011141822A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8475775B1 (en) * 2012-08-24 2013-07-02 The Uab Research Foundation Retinoids and use thereof
EP3649950A4 (en) * 2017-07-07 2020-06-03 Panasonic Intellectual Property Management Co., Ltd. Information provision method, information processing system, information terminal, and information processing method
EP3650858A4 (en) * 2017-07-07 2020-05-27 Panasonic Intellectual Property Management Co., Ltd. Information provision method, information processing system, information terminal, and information processing method
CN110546501B (en) * 2017-07-07 2022-01-11 松下知识产权经营株式会社 Information providing method, information processing system, information terminal, and information processing method
CN110612445B (en) * 2017-07-07 2022-07-08 松下知识产权经营株式会社 Information providing method, information processing system, information terminal, and information processing method
CN110537097B (en) * 2017-07-07 2022-03-08 松下知识产权经营株式会社 Information providing method, information processing system, information terminal, and information processing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
DE102005020229A1 (en) * 2005-04-30 2006-11-09 Bayer Healthcare Ag Use of indoline-phenylsulfonamide derivatives
JP2008247829A (en) * 2007-03-30 2008-10-16 National Institute Of Advanced Industrial & Technology Therapeutic agent for rhythm trouble containing ligand of intranuclear receptor
WO2010068750A2 (en) * 2008-12-11 2010-06-17 Board Of Trustees Of Leland Stanford Junior University Compositons and method for treatment of mood and cognitive impairments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
DE102005020229A1 (en) * 2005-04-30 2006-11-09 Bayer Healthcare Ag Use of indoline-phenylsulfonamide derivatives
JP2008247829A (en) * 2007-03-30 2008-10-16 National Institute Of Advanced Industrial & Technology Therapeutic agent for rhythm trouble containing ligand of intranuclear receptor
WO2010068750A2 (en) * 2008-12-11 2010-06-17 Board Of Trustees Of Leland Stanford Junior University Compositons and method for treatment of mood and cognitive impairments

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LOGAN ALAN C: "Omega-3 fatty acids and major depression: A primer for the mental health professional", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, vol. 3, no. 1, 9 November 2004 (2004-11-09), pages 25, XP021008308, ISSN: 1476-511X, DOI: 10.1186/1476-511X-3-25 *
VAN NEERVEN S ET AL: "RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases", PROGRESS IN NEUROBIOLOGY, PERGAMON PRESS, GB, vol. 85, no. 4, 1 August 2008 (2008-08-01), pages 433 - 451, XP023521896, ISSN: 0301-0082, [retrieved on 20080504], DOI: 10.1016/J.PNEUROBIO.2008.04.006 *

Also Published As

Publication number Publication date
WO2011141822A2 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
WO2011141822A3 (en) Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors
Parrell et al. Impaired feedforward control and enhanced feedback control of speech in patients with cerebellar degeneration
MY195224A (en) FXR (NR1H4) Modulating Compounds
MX2013012526A (en) Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders.
PH12016500818A1 (en) Process for synthesis of an indoleamine 2,3-dioxygenase inhibitor
SG10201807427RA (en) Method of cleansing the colon
ATE539743T1 (en) METHOD FOR PREVENTING AND TREATING PPAR-MEDIATED CONDITIONS USING MACELIGNAN
WO2011127211A3 (en) Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
WO2009035627A3 (en) System and method for tissue change monitoring during hifu treatment
ATE499656T1 (en) FLUID-PROCESSING MEDICAL DEVICE AND METHOD FOR SETTING UP A FLUID-PROCESSING MEDICAL DEVICE
WO2013039577A3 (en) Monitoring task engagement using beta oscillations
EA202092779A1 (en) SUBSTITUTED DIHYDROPYRAZOLOPYRAZINE CARBOXAMIDE DERIVATIVES
MX2011008602A (en) Methods of treating hair related conditions.
ATE528289T1 (en) 1,2-DISUBSTITUTED 4-BENZYLAMINOPYRROLIDINE DERIVATIVES AS CETP INHIBITORS SUITABLE FOR THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA OR ARTERIOSCLEROSIS
MA38333A1 (en) Azabenzimidazole compounds as pde4 isozyme inhibitors for the treatment of disorders of snc and other conditions
SG194471A1 (en) Method of treating vision disorders
MX2016010029A (en) Camera-based monitoring of vital signs of during phototherapy treatment.
MA39171A1 (en) Hydroxy formamide derivatives and their use
MX2013008699A (en) Compounds for the reduction of î²-amyloid production.
EA201291040A1 (en) USE OF THE VELOCITY INCREASE DURING THE TREATMENT OF ALCEHEMER'S Disease By Intravenous Immunoglobulin
FR2971719B1 (en) DEVICE FOR COATING A FLUID-PRODUCING OBJECT WITH AN ASSOCIATED DISTRIBUTION AND PROCESSING ASSEMBLY
CY1115941T1 (en) METHOD AND WATER CLARIFICATION APPLIANCE FOR COLOID TREATMENT
CY1111730T1 (en) GABAPENTINI PREPARATION PROCEDURE
FR3000456B1 (en) METHOD AND DEVICE FOR CONTROLLING A WASHING DEVICE BY A CONTROL AND/OR REGULATION UNIT
EP2659801A4 (en) Automatic head care apparatus and automatic head care method

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11743613

Country of ref document: EP

Kind code of ref document: A2